KEGG: ypg:YpAngola_A1202
YedZ functions as a heme-binding subunit of the sulfoxide reductase system in Yersinia pestis. It belongs to the same family of enzymes as the TorZ/MtsZ system found in other bacterial species, which has been characterized as an S- and N-oxide reductase with specificity for S-sulfoxides . Unlike some other reductases that only reduce N-oxides, YedZ possesses critical tyrosine and tryptophan residues in its active site that enable it to reduce both S- and N-oxides . This is consistent with the broader pattern observed in combined S- and N-oxide reductases which contain both active site residues, while true N-oxide reductases like TorA lack the tyrosine residue .
The recombinant expression of Y. pestis proteins, including YedZ, typically employs vector-based systems with electroporation as the primary transformation method. Based on established protocols for Y. pestis proteins, the gene encoding YedZ can be inserted into a suitable expression vector similar to the technique used for GFP expression in Y. pestis . The transformation protocol typically involves preparing electrocompetent Y. pestis cells from natural strains, followed by electroporation of the vector containing the yedZ gene . After transformation, antibiotic selection (commonly using ampicillin) helps isolate transformants, which are then verified through molecular-genetic methods to confirm the presence and expression of the recombinant YedZ protein .
Recombinant expression can introduce several functional differences compared to native expression. Based on studies of similar systems, recombinant YedZ may exhibit altered catalytic efficiency depending on the expression system used. When expressing sulfoxide reductases recombinantly, proper incorporation of cofactors (particularly the heme group for YedZ) is critical for maintaining functionality . Expression levels must be optimized to prevent aggregation of the membrane-associated YedZ protein. Additionally, post-translational modifications present in native YedZ may be absent in recombinant systems, potentially affecting substrate specificity or catalytic rates. Researchers should verify the functional integrity of recombinant YedZ through activity assays comparing its ability to reduce model substrates such as methionine sulfoxide or biotin sulfoxide against purified native enzyme .
To effectively assess YedZ's role in virulence, a multi-faceted approach combining genetic manipulation, in vitro assays, and in vivo models is recommended. First, create yedZ gene knockout mutants in Y. pestis using homologous recombination or CRISPR-Cas9 techniques. Compare these knockout strains with complemented strains (where yedZ is reintroduced) and wild-type strains across the following parameters:
Biofilm formation capacity using crystal violet staining and confocal microscopy
Survival rates within biofilms when exposed to oxidative stress
Interactions with host cells using fluorescently labeled bacteria (similar to GFP-expressing Y. pestis constructs)
In vivo virulence assessment in murine infection models
Research on similar reductases suggests that knockout strains may show significantly reduced biofilm formation and impaired host-cell interactions . For example, studies on TorZ/MtsZ demonstrated that strains lacking this enzyme were almost undetectable after 72 hours of infection, while approximately 3.6 × 10³ CFU/mL of wild-type strains remained viable under identical conditions .
The substrate specificity of YedZ can be determined through a systematic enzymatic analysis approach:
Methodological Protocol:
Express and purify recombinant YedZ using affinity chromatography
Conduct enzyme activity assays with various potential substrates including:
Methionine sulfoxide (MetSO)
Biotin sulfoxide (BSO)
Dimethyl sulfoxide (DMSO)
Trimethylamine N-oxide (TMAO)
Determine kinetic parameters (Km, Vmax, kcat) for each substrate
Perform site-directed mutagenesis of key active site residues (particularly the tyrosine and tryptophan residues) to assess their contribution to substrate preference
Example Kinetic Parameters Table:
| Substrate | Km (μM) | Vmax (μmol/min/mg) | kcat (s⁻¹) | kcat/Km (M⁻¹s⁻¹) |
|---|---|---|---|---|
| MetSO | 45 ± 5 | 12.4 ± 1.1 | 8.5 ± 0.7 | 1.9 × 10⁵ |
| BSO | 120 ± 12 | 8.3 ± 0.9 | 5.7 ± 0.5 | 4.8 × 10⁴ |
| DMSO | 380 ± 35 | 3.2 ± 0.4 | 2.2 ± 0.3 | 5.8 × 10³ |
| TMAO | 450 ± 40 | 2.8 ± 0.3 | 1.9 ± 0.2 | 4.2 × 10³ |
Based on similar reductases, MetSO is likely to be the preferred substrate as indicated by the higher kcat/Km value . Understanding YedZ's substrate preference provides insights into Y. pestis metabolism, particularly its adaptation to oxidative stress environments encountered during host infection. The inability to reduce protein-bound sulfoxides (as seen with similar enzymes unable to repair oxidized Calmodulin) suggests YedZ may function primarily in cellular metabolism rather than protein repair mechanisms .
Crystallizing membrane proteins like YedZ presents significant challenges due to their hydrophobic nature. The following methodological approach addresses these challenges:
Protein Engineering Strategies:
Create truncated constructs removing highly flexible regions
Design fusion proteins with crystallization chaperones (e.g., T4 lysozyme, BRIL)
Introduce surface entropy reduction mutations to promote crystal contacts
Detergent Screening Protocol:
Systematically test a panel of detergents (n-Dodecyl β-D-maltoside, n-Octyl-β-D-glucoside, LDAO, etc.)
Assess protein stability in each detergent using thermal shift assays
Evaluate monodispersity through size exclusion chromatography
Crystallization Approaches:
Lipidic cubic phase (LCP) crystallization for membrane proteins
Bicelle crystallization method
Vapor diffusion with specific additives (e.g., heme cofactors, substrate analogs)
Alternative Structural Methods:
Cryo-electron microscopy for membrane proteins resistant to crystallization
NMR spectroscopy for dynamic regions
Expected Outcomes Table:
| Method | Resolution Range | Advantages | Limitations |
|---|---|---|---|
| X-ray crystallography with LCP | 1.5-3.0 Å | High resolution, captures active site details | Requires well-diffracting crystals |
| Cryo-EM | 2.5-4.0 Å | No crystallization needed, captures different conformations | Lower resolution for smaller proteins |
| NMR | Site-specific information | Provides dynamic information | Limited to smaller constructs |
Success has been achieved with similar heme-binding proteins by including the heme cofactor during purification and crystallization steps, as this enhances protein stability and provides a structured region that can facilitate crystal contacts.
A comprehensive experimental design should include:
Growth and Survival Assays:
Compare wild-type, ΔyedZ knockout, and complemented strains
Expose cultures to increasing concentrations of H₂O₂, superoxide, or nitric oxide donors
Measure survival rates at different timepoints (0, 2, 4, 8, 24 hours)
Include relevant controls (e.g., strains with known oxidative stress response genes knocked out)
Gene Expression Analysis:
Perform RNA-Seq or qRT-PCR on wild-type vs. ΔyedZ strains under oxidative stress
Monitor expression changes in related oxidative stress response genes
Use time-course experiments to capture dynamic responses
Biochemical Characterization:
Measure intracellular redox state using redox-sensitive fluorescent proteins
Quantify levels of oxidized biomolecules (proteins, lipids, DNA) in wild-type vs. ΔyedZ strains
Monitor the reduction rate of key sulfoxides in cell extracts
Based on studies with similar bacterial reductases, researchers should pay particular attention to the bacterium's ability to survive within macrophages, as these cells generate high levels of reactive oxygen species . The Experimental Design Assistant (EDA) can be valuable for planning these experiments, helping researchers identify variables that could confound outcomes and providing advice on randomization and statistical analysis .
When designing experiments to assess how YedZ mutations impact Y. pestis virulence, researchers should implement the following controls and variables:
Essential Controls:
Wild-type Y. pestis strain (positive control for virulence)
Complete yedZ deletion mutant (negative control)
Complemented strain (yedZ gene reintroduced on plasmid)
Site-directed mutants targeting only the active site residues
Non-virulent Y. pestis strain (laboratory attenuated)
Critical Experimental Variables:
Mutation Types:
Catalytic residue mutations (active site tyrosine and tryptophan)
Heme-binding site mutations
Membrane anchoring domain mutations
Regulatory region mutations
Infection Models:
Cell culture systems (macrophages, epithelial cells)
Insect models (fleas as natural vectors)
Rodent models (mice with varying genetic backgrounds)
Measurement Parameters:
Bacterial load in tissues
Survival rates
Cytokine/chemokine profiles
Histopathological changes
The EDA tool can help researchers develop a rigorous experimental design by providing an explicit diagram of the experimental plan and generating a randomization sequence that accounts for blocking factors . This approach ensures that the experiments avoid common pitfalls in design and analysis, ultimately improving the reproducibility of results .
Creating a fluorescently tagged YedZ construct requires careful consideration to maintain protein function. The following methodological approach is recommended:
Construct Design Strategy:
Perform in silico structural analysis to identify optimal fusion sites
Create multiple constructs with the fluorescent tag at:
C-terminus (less likely to disrupt function if C-terminus is cytoplasmic)
N-terminus (if N-terminus is not involved in membrane insertion)
Internal loops (if identified as flexible and surface-exposed)
Consider using small fluorescent tags (e.g., FlAsH tag) if protein size is a concern
Include flexible linkers (GGGGS)n between YedZ and the fluorescent protein
Validation Protocol:
Confirm proper membrane localization using membrane fractionation
Verify fluorescent signal colocalizes with membrane markers
Conduct enzymatic activity assays to ensure the tagged protein retains function
Compare growth characteristics and stress responses to untagged YedZ
Drawing on experience with GFP-tagged Y. pestis constructs, electroporation has proven to be an effective method for introducing the recombinant constructs . After transformation, it's essential to verify that the fluorescently tagged strain maintains the same cultural-morphological and biochemical properties as the original strain .
When faced with discrepancies between in vitro and in vivo results regarding YedZ function, researchers should implement this systematic approach:
Methodological Reconciliation:
Examine differences in experimental conditions (pH, temperature, ionic strength)
Assess whether the protein preparation maintains native conformation and cofactors
Verify that in vitro substrates reflect physiological concentrations and compositions
Integrative Analysis Framework:
Perform correlation analyses between in vitro activity and in vivo phenotypes
Use mathematical modeling to account for differences in substrate availability
Consider cellular compartmentalization effects absent in purified systems
Complementary Approaches:
Develop cell-based assays that bridge the gap between purified enzymes and animal models
Use chemical biology approaches (e.g., activity-based protein profiling) to monitor enzyme activity in living cells
Implement proteomics to identify interaction partners present in vivo but absent in vitro
Similar challenges have been documented with other bacterial reductases, where enzymatic preferences observed in vitro (such as the preference for methionine sulfoxide) needed to be validated in cellular contexts to confirm physiological relevance .
For robust statistical analysis of YedZ knockout phenotypes in virulence studies, researchers should consider:
Experimental Design Considerations:
Use power calculations to determine appropriate sample sizes
Implement randomization to minimize bias
Ensure proper blinding during data collection and analysis
Include relevant blocking factors (e.g., animal age, weight, sex)
Statistical Methods Based on Data Type:
For survival data: Kaplan-Meier survival analysis with log-rank tests
For bacterial burden: Mixed-effects models to account for repeated measures
For multiple cytokine measurements: Multivariate analysis with appropriate corrections for multiple comparisons
For binary outcomes: Logistic regression with relevant covariates
Advanced Analysis Approaches:
Principal Component Analysis for dealing with multiple correlated phenotypes
Bayesian hierarchical modeling for integrating data across different experimental scales
Machine learning algorithms for identifying patterns in complex phenotypic data
The Experimental Design Assistant (EDA) can be particularly helpful in identifying the appropriate statistical methods based on the experimental design . It helps researchers avoid common pitfalls in statistical analysis by providing tailored critique and suggestions for optimization .
Integrating metabolomics with genetic studies offers powerful insights into YedZ function:
Methodological Integration Framework:
Experimental Design:
Compare metabolite profiles of wild-type, ΔyedZ, and complemented strains
Include strains with point mutations in key residues
Sample at multiple timepoints during growth and under various stress conditions
Analyze both intracellular metabolites and secreted compounds
Analytical Approaches:
Targeted LC-MS/MS for known sulfoxide-containing metabolites
Untargeted metabolomics to discover novel YedZ substrates
Stable isotope labeling to track sulfoxide metabolism
Flux analysis to determine the impact of YedZ on metabolic pathways
Data Integration Strategy:
Correlate metabolite changes with transcriptomic alterations
Map identified metabolites to biochemical pathways
Use network analysis to identify metabolite clusters affected by YedZ
Validate key findings with isotope-labeled substrate feeding experiments
Example Integration Results Table:
| Metabolite | Fold Change in ΔyedZ | Associated Pathway | Correlated Gene Expression Changes |
|---|---|---|---|
| Free MetSO | +3.8 | Methionine metabolism | Upregulation of alternative reductases |
| Biotin sulfoxide | +2.4 | Biotin metabolism | Downregulation of biotin-dependent enzymes |
| DMSO | +1.2 | Anaerobic respiration | Minimal changes in respiratory genes |
| TMAO | +0.9 | Anaerobic respiration | No significant changes |
Based on studies of similar reductases, MetSO is likely to accumulate significantly in ΔyedZ strains, as it appears to be the preferred substrate for this class of enzymes . This integrated approach would help determine whether YedZ functions primarily in sulfoxide-based energy generation or in maintaining redox homeostasis within the bacterial cell.
Purifying active YedZ presents several challenges due to its membrane localization and heme cofactor requirement. The following methodological approach addresses these issues:
Expression System Optimization:
Test multiple expression systems (E. coli, Y. pestis, cell-free)
Use inducible promoters with tunable expression levels
Supplement growth medium with δ-aminolevulinic acid to enhance heme biosynthesis
Consider low-temperature induction to improve proper folding
Extraction and Solubilization Protocol:
Screen detergents systematically (starting with mild detergents like DDM, LMNG)
Optimize detergent-to-protein ratios to prevent aggregation
Include stabilizing agents (glycerol, specific lipids) in buffers
Test membrane scaffold proteins or nanodiscs for native-like environment
Purification Strategy:
Implement two-step affinity chromatography (e.g., IMAC followed by heme-affinity)
Use size exclusion chromatography to confirm monodispersity
Monitor heme content spectroscopically throughout purification
Verify activity at each purification step
Activity Preservation Measures:
Maintain reducing conditions to prevent oxidation of critical thiols
Include substrate analogs or inhibitors to stabilize active conformation
Optimize buffer composition based on thermal stability assays
Consider rapid purification protocols to minimize time ex vivo
Similar challenges have been reported for other bacterial reductases, where maintaining the proper cofactor association during purification was critical for preserving enzymatic activity .
Distinguishing direct from indirect effects requires a multi-faceted approach:
Genetic Complementation Strategy:
Create a complementation library with:
Wild-type YedZ
Catalytically inactive YedZ (active site mutations)
Structural variants (affecting localization but not activity)
Use inducible expression systems to control timing and level of complementation
Implement domain swapping with homologous proteins to identify critical regions
Temporal Analysis Framework:
Perform time-course experiments to establish the sequence of events
Use pulse-chase approaches to determine primary vs. secondary effects
Implement inducible gene expression/repression systems for temporal control
Biochemical Validation Approaches:
Conduct in vitro reconstitution experiments with purified components
Use substrate analogs and specific inhibitors to confirm direct targets
Implement chemical genetics approaches with engineered sensitivity
Systems-Level Analysis:
Integrate transcriptomics, proteomics, and metabolomics data
Construct network models to identify direct YedZ targets
Validate predictions using targeted interventions
Similar strategies have been employed when studying other bacterial enzymes involved in host-pathogen interactions, where careful genetic complementation experiments helped distinguish between direct enzymatic effects and indirect consequences of protein absence .